1. Puzzling Out the Genetic Architecture of Endometriosis: Whole-Exome Sequencing and Novel Candidate Gene Identification in a Deeply Clinically Characterised Cohort
   Aurora Santin et al, 2023, Biomedicines CrossRef
2. Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta
   Sungsam Gong et al, 2018, Epigenetics CrossRef
3. The Role of Csmd1 during Mammary Gland Development
   Samuel J. Burgess et al, 2021, Genes CrossRef
4. RAS internal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling
   Andrew C. Nelson et al, 2020, Journal of Biological Chemistry CrossRef
5. Analyses of multi-omics differences between patients with high and low PD1/PDL1 expression in lung squamous cell carcinoma
   Zhengyang Hu et al, 2020, International Immunopharmacology CrossRef
6. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets
   Job van Riet et al, 2021, Nature Communications CrossRef
7. Analysis of multiple basal cell carcinomas (BCCs) arising in one individual highlights genetic tumor heterogeneity and identifies novel driver mutations
   Pingxing Xie et al, 2022, Journal of Cell Communication and Signaling CrossRef
8. Novel potential inhibitors of complement system and their roles in complement regulation and beyond
   Chrysostomi Gialeli et al, 2018, Molecular Immunology CrossRef
9. CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer
   Xin Fan et al, 2021, International Journal of General Medicine CrossRef
10. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases
    Esra Ermis Akyuz et al, 2022, Genes CrossRef
11. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis
    Haofeng Liu et al, 2022, Bioengineered CrossRef
12. CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma
    Xing Wang et al, 2022, Experimental Cell Research CrossRef
13. Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy
    Chrysostomi Gialeli et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
14. Inhibition of CUB and sushi multiple domains 1 (CSMD1) expression by miRNA-190a-3p enhances hypertrophic scar-derived fibroblast migration in vitro
    Shuchen Gu et al, 2021, BMC Genomics CrossRef
15. Stilbenoid‐Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor
    Megan Beetch et al, 2019, Molecular Nutrition & Food Research CrossRef
16. Role of ERα and Aromatase in Juvenile Gigantomastia
    Richard J Santen et al, 2024, The Journal of Clinical Endocrinology & Metabolism CrossRef